Proteomics data have been obtained from experimental mastitis in ewes after intramammary challenge with Mannheimia haemolytica. Animals were sampled before and sequentially after challenge; blood plasma and milk whey samples were produced and were subjected to proteomics evaluation by means of two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry. Full protein maps and differential proteomics in sequential samples from blood plasma and milk whey of experimental ewes were presented. Post-challenge, 33 and 89 proteins were identified with differential abundance in blood plasma and milk whey, respectively. Also, 74 proteins were identified with differential abundance between the inoculated and contralateral glands. The data provide further insight in the pathogenesis of mastitis in sheep and indicate potential biomarkers for the disease. The data are further discussed in the research article "Differential quantitative proteomics study of experimental Mannheimia haemolytica mastitis in sheep" [1] .
Data
After intramammary challenge of ewes with Mannheimia haemolytica, mastitis was induced, which was confirmed by clinical, microbiological, cytological and histopathological ( Fig. 1) findings. Details of proteins obtained from blood plasma (Table 1 , Fig. 2 ) and milk whey (Table 2, Fig. 3 ) samples collected before, as well as from milk whey samples obtained 12 h after (Table 3 , Fig. 4 ) intramammary challenge with Mannheimia haemolytica were presented [1] . In the blood plasma and milk whey samples collected before inoculation, 19 and 40 proteins, respectively, were identified. In the milk whey sample collected post-inoculation, 65 proteins were identified.
Additionally, tabulated lists of observed proteins with changes in abundance, in post-challenge samples of blood plasma (Table 4) , of milk whey of the inoculated side of the udder (Table 5 ) and of milk whey of the contralateral side of the udder (Table 6 ), collected sequentially, were also presented. In total, 33, 89 and 20 proteins with differential abundance were identified in the respective samples. Changes in protein abundance were separated into different classifications: (i) decrease (6, 18 and 1 proteins, respectively), (ii) new appearance (13, 53 and 8 proteins, respectively), (iii) increase (0, 3 and 0 proteins, respectively) and (iv) varying abundance (14, 15 and 11 proteins, respectively).
Finally, 79 proteins with differential abundance were identified between milk whey samples collected from the inoculated (74 proteins) and contralateral (5 proteins) glands of the experimental ewes (Table 7) .
Experimental design, materials and methods
After intramammary inoculation of one mammary gland of ewes (n ¼ 5) with Mannheimia haemolytica (1000e1250 cfu) performed on Day-0 (D0), mastitis was induced, as confirmed by clinical, Specifications Value of the data Proteomics data from blood plasma and milk whey samples from ewes with experimental mastitis caused by Mannheimia haemolytica and the differential proteomics in sequential samples after challenge are presented for the first time.
The data can be used for comparison to proteomics data from mastitis caused by other pathogens. Potential biomarkers can be selected among the proteins identified for improved diagnosis of the infection. microbiological, cytological and histopathological methods. The uninoculated mammary gland (contralateral) was used as uninfected control. Before challenge (on D0), as well as sequentially after that (on D0 þ 12 h, D1, D2, D3, D4), animals were sampled. In milk samples collected from all ewes on D1, increased somatic cell counts and M. haemolytica recovery were simultaneously recorded. Histopathological confirmation of mastitis was provided by histopathological examination of mammary biopsy tissue samples performed 3 or 4 days post-challenge. Blood plasma and milk whey prepared from the samples were processed for proteomics examination. Two-dimensional gel electrophoresis was performed by using 18 cm, pI 3e10 NL, IPG strips (BioRad, Hercules, USA) [2] . Second-dimensional electrophoresis was performed on non-gradient 12% SDSpolyacrylamide gels, which were stained by colloidal Coomasie blue dye (Colloidal Blue staining kit; Thermo Fisher Scientific, Waltham, USA). Protein spots from all gels analysed were detected, aligned, matched and quantified using the PD-Quest v8.0 image processing software (Bio-Rad). Manual inspection of the spots was used to verify the accuracy of matching.
In four gels, all spots on each gel were considered as protein spots of interest for Mass Spectrometry identification. These gels were produced from following samples: (i) blood plasma sample from one ewe collected before challenge (D0), (ii-iii) two milk whey samples from two ewes from the side of the udder that was scheduled for inoculation before challenge (D0), (iv) one milk whey from one ewe from the inoculated side of the udder immediately after challenge (D0 þ 12 h). 'Full protein maps' were produced from these four samples.
In the remaining gels, differential proteomics evaluation was performed. Protein spots of interest were detected, aligned and matched between: (i) gels from sequential blood plasma samples from ewes, (ii) gels from milk whey samples from the two mammary glands of each ewe (inoculated side versus non-inoculated side) on the same sampling point and (iii) gels from sequential milk whey samples from the mammary glands of ewes using the PD Quest v.8.0 image processing software (BioRad). Differential abundance of proteins on each sampling time-point after challenge was evaluated in comparison with the respective protein before challenge (i.e., on D0). Protein decrease was defined when (i) proteins had been identified on D0, but not after challenge, or (ii) when protein spot densities after challenge were significantly lower than on D0. Protein new appearance was defined when proteins were detected only after challenge. Protein increase was defined when protein spot densities after challenge were significantly higher than on D0. Finally, protein varying abundance was defined when (i) proteins had been identified both on D0 and intermittently after challenge or (ii) protein spot densities post-challenge had not been significantly lower or higher than on D0.
Protein identification was performed by peptide mass fingerprinting. In the four gels in which all spots on each gel were considered as protein spots of interest, these were annotated by using the Melanie v.4.02 software (Swiss Institute of Bioinformatics, Lausanne, Switzerland). In the remaining 
Brain-specific angiogenesis inhibitor 1-associated protein 2 gels, protein spots of interest were annotated manually using the Melanie 4.02 software and were excised from 2D-gels by use of Proteiner SPII (Bruker Daltonics, Bremen, Germany). All excised spots were subjected to tryptic digestion. Then, peptide mixtures were analysed in a MALDI-TOF mass spectrometre (Ultraflex, Bruker Daltonics) [3] . Matching of peptides and protein searches were carried out in the MASCOT Server 2 (Matrix Science, Boston, USA). Masses of peptides were searched under 'mammalia', but excluding 'Homo sapiens' and 'rodents', in the UniProt Knowledge base database (UniProtKB/Swiss-Prot [release 2014 12]) [4] . 
Phosphoglucomutase-1 -✓ ✓: protein observed with differential abundance in milk sample from respective mammary gland from at least one ewe; -: protein not observed with differential abundance in milk sample from respective mammary gland in any ewe.
